NKB1 is one member ofa ~owing family ofkiUer cell inhibitory receptms (K/R~. It is expressed on natural kilIer (NK) cells and T cells, and has been showrt to inhibit cytolytic s tions of these cells upon interacting ~th its hga~,, HLA-B (Bw4). We demongrate he_xe that the cytoplasmic' region of NKB1 is capab~ of inhibiting T cell, activation m jmrkat cdls. ~e ty~osme phosphorylation of the NKBI KtR consensus motif, YxxL(x)~YxxL, induces an amoc/afion with the protein tyrosine phosphat~.se 1C (PTPIC). Im~rtantly, mutation of both tyrosines in the motif a~ecl, the inhibitory functions of NKB1 and ahrt~ted PTIrtC tion. Mutational analysis of the individual tyrosines suggest that the membrane pro.xim~ tyrosine may play a crtrdal role in mediating the inh/bitory signal. These results ~~ that KIR can not only inhibit cytolytic activity, but can also negatively regulate T ceil receptor activation events that lead to downstream gene activation, and further supports a model that implicates PTP1C as a mediator in the KI~ inhibitory signal.
"~riller cell inhibitory receptors (KIR), a growing hmiIy 1~1,.of receptors that are present on NK cells and on subsets of peripheral T cells, inhibit cytolytic activi W by recognizing polymorphic MHC class I molecules on target cells (1) . NK cells, important in innate immune respomes, recognize and kill tumor cells, virus-infected cells, and cells lacking MHC class I antigens. The effector functions of NK cells, cytolytic activity and cytokine secretion, appear to be the result of a finely regulated balance between positive signals that initiate the response and negative signals that inhibit the activated state (1) . KIK appear to be important reguhtory molecules of NK cell effector functions.
The KIR present on peripheral T cells also inhibit killing of target cells expresfmg art appropriate MHC class I ligand (2, 3) . Although the positive signals through the antigen receptor resulting in T cell activation are well defined (4), litde is known about the signals that may regulate the extent or degree ofT cell activation. The presence of KilL on T cells offers an intriguing candidate for a negative regulatory molecule of cytolytic and noncytolytic functions.
The cytoplasmic tails of the KIR contain the consensus motif D/E(x)2YxxL(x)26YxxL (5--7), which is reminiscent of the irranunoreceptor tyrosine-based activation motif (ITAM) (D/E(x)2YxxL(x)7_sYxxL) present in TCtL and BCtL subunits (4) . In T and B cells, the tyrosines (Y) in the I~TAM motif become phosplmcyhted atier receptor stim~ lation, and they mediate interaction with the Src homolog~f 2 (SH2) domains of the ZAP-70/Syk ~ma-ly Oflma~em tyrosine kinases fPTK; 8). The tymanes m the c~o~h~r region of the KIR nmy ~ be invoked in S/-12 im~ac-lions. Recerrdy, a study by Burshtyn et aL (9) showed ffrat the KIR p58 can bind to the protein tyrosine phospbatase 1C (PTP1C). PTP1C (SHP-1, HCP, SH-PTPI) is ~ 66-kD protein and a member of the cytoplasmic, SH2 domecontaining family of phosphahas~ which im:ludes PTPID (SHP-2, Syp, SH-PTP2) and the Dmsold~ protein r screw (10). PTP1C has. been shown to become induci~ associated with the erythropoietin receptor (F4x)P~,, Fc'~IIB1, CD22, c-k/t, and the ILL-3 receptor I~ chain as stimulation of these receptors (I1-15). Recent stud/es, correlate the binding of PTPt C with the negative regt~tior~ of the EpoR and the negative reguhtion ~R-rrte~a~ed activation by Fc~/RIIB1 (11, 12) . Additionally, mutations in the PTP1C gene have been linked to the severe hematopoietic defects in motheaten (me) and motheaten viable (mev) mice .
In this report, we study the inhibito~ fnnctmn of the KIR NKBI m T cells. Transient ~on os a CD8t NKB1 chimera in lurk, at T ce~ attowed analyses of the structural requirements of NKBI necessary for the inhibi-tion of TCR activation. We demonstrate that the cytoplasmic region of NKB1 inhibited TClL-mediated downstream gene activation in Jurkat T cells, and that tyrosine phosphorylation of NKB1 induced an association between PTP1C and the chimeric receptor. Also, mutational analysis of the tyrosines in the KIR consensus motif established the requirement of phosphotyrosines for the inhibitory functions of NKB1 and for association with PTP1C.
Materials and Methods
Cells. Jurkat cells and Raji cells were maintained in RPMI 1640 medium supplemented with 5% FCS, penicillin, streptomycin, and glutamine, as previously described (19) .
Plasmids. The CD8/T construct was described previously (19 , Sarasota, FL) in the concentrations indicated were added to each well. As a control for NFAT activation, cells were stimulated with 50 ng/ nO PMA and 1.0 I~M ionomycin. The average value of the PMA and ionomycin stimulation was used as a maximum stimulation value. After 6-8 h at 37~ cells were lysed and luciferase activation was determined as described previously (20) . Activation for each condition was determined in duplicate, and each experiment was repeated at least three times. The percent maximum stimulation value achieved with 300 ng/ml SED plus Raji was averaged from three independent experiments for each plasmid.
Antibodies and Flow Cytometry. 4G10, an antiphosphotyrosine mAb, was purchased from Upstate Biotechnology, Inc. (Lake Placid, NY). Anti-PTP1C is a rabbit anti-mouse serum (generously provided by Dr. J. Schlessinger, New York University, New York). OKT8 mAb recognizes an extracellular epitope of CD8 and was acquired from American Type Culture Collection (Rockville, MD). Anti-Zap-70 mAb has been described previously (21) . Peptides and Peptide-binding Assays. The peptides were synthesized in a peptide synthesizer (Applied Biosystems, Inc., Foster City, CA), as previously described (21) . The peptide sequence is: DPQEVT(Y) ITQLNHCVFTQRKITRPSQRPKTPPTDIIVCY) 2TELPNAESR. Peptides were phosphorylated as follows: P1 peptide on Y1; P2 peptide on Y2; P1P2 peptide on Y1 and Y2. P0 was unphosphorylated. The { peptides are described elsewhere (21) . Peptide precipitation was performed with avidin-conjugated beads (Vector Laboratories, Burlingame, CA), as previously described (21) . Methods for [3SS]methionine biosynthetic labeling were described previously (23) .
Western Blotting and Immunoprecipitation. 2 • 107 Jurkat cells
were transiently transfected with 40 ~g of the CD8/NKB1 or 20 ~g of the FIF2 (plus 20 Ixg pEF Bos with no insert). 24-40 h later, 106 cells were analyzed by flow cytometry for surface CD8 expression, and the remaining cells were stimulated with pervanadate (10 mM Na-orthovanadate, 3.36% H202) for 10 rain at 37~ The cells were then lysed in buffer containing 1% NP-40, 10 mM Tris (pH 7.8), 150 mM NaC1, 2 mM EDTA, and protease and phosphatase inhibitors, as previously described (20) . Lysates were immunoprecipitated with 2 ~10KT8 ascites or 4 ~1 anti-PTP1C serum and protein G-Sepharose (Pharmacia, Alameda, CA). The precipitates were separated by SDS-PAGE and transferred to Immobilon-P membranes (Millipore, Bedford, MA). The blots were blocked, as described previously (20) and then incubated with primary antibody, followed by secondary step reagent conjugated with horseradish peroxidase (protein A-HRP; Amersham, Arlington Heights, IL) or goat anti-mouse IgG-HRP (Southern Biotechnology Associates, Birmingham, AL). Proteins were detected by enhanced chemiluminescence (ECL kit; Amersham).
Results and Discussion

PTPI C-1 Associates with Doubly Tyrosine-phosphorTlated KIR Peptides.
To identify proteins associated with the cytoplasmic region of the KIR that may be involved in signal transduction, we generated biotinylated peptides corresponding to the KIR consensus motif of NKAT1 (aa 295-341 [5] ) and used these peptides to precipitate proteins from metabolically labeled ceils. The peptides were either unphosphorylated (P0) or, phosphorylated on the first (membrane proximal) (P1), the second (carboxy-terminal) (P2), or both tyrosines (P1P2). Only the PlP2 peptide was found to bind to a distinct 66-kD band in 3SS-metabolicaily labeled lysates from Jurkat ceils (data not shown). Western blot analyses using antisera against known SH2 domaincontaining proteins in this molecular mass range identified PTP1C as one 66-kD protein that could bind to the doubly phosphorylated peptide (Fig. 1) . The P1P2 peptide bound to PTP1C in a dose-dependent manner. Conversely, the doubly phosphorylated ~ peptide bound to ZAP-70, but not to PTP1C, confirming the specificity of the interaction. Phosphorylation of both tyrosines was required for in vitro binding, since the single phosphotyrosine peptides did not bind to PTP1C. Therefore, PTP1C associated with the doubly tyrosine phosphorylated KIR peptide but not to the unphosphorylated or singly tyrosine phosphorylated peptides.
These peptide binding study results differ from those by Burshtyn et al., who showed PTP1C association with single phosphotyrosine peptides (9) . This may represent dif- 
PTP1C Associates with the Cytoplasmic Region of NKB1.
To further study the mechanisms by which NKB1 mediates negative signaling in T cells and whether this involves P T P I C binding, we constructed a C D 8 / N K B 1 chimeric expression vector. This construct, containing the extracellular and transmembrane region o f the CD8 molecule and the intracellular region of NKB1, was transiently transfected into Jurkat T cells. W e also mutated the first (F1), the second (F2), or both tyrosines to phenylalanine (F1F2) in the K I R consensus motif of N K B I (Fig. 2 A) and transfected these into Jurkat cells.
The transfected cells were stimulated with pervanadate, a phosphatase inhibitor that induces maximal tyrosine phosphorylation (24), lysed, and the C D 8 / N K B 1 chimera proteins precipitated. The C D 8 / N K B 1 proteins were resolved by SDS-PAGE and blotted with a n t i -P T P I C . As shown in lated protein in the pervanadate-stimulated cell lysate, consistent with the migration of the chimera protein (Fig. 2 B, lower panel). Similarly, the C D 8 / N K B 1 chimera was detected in P T P 1 C immunoprecipitates (data not shown). Therefore, the phosphotyrosines in the KIP, motif of NKB1 are necessary for PTP1C association. These results are consistent with the in vitro peptide-binding studies presented above,
The Cytoplasmic Domain of NKB1 Is Capable of Inhibiting TCR Activation. The in vivo transient expression system described above also allowed us to assess the functional effect of NKB1 expression on TCR.-mediated signal transduction. Activation through the T C R was achieved by stimulation with the superantigen, SED, presented by the Raji B cell line, and was monitored by transcriptional activation of the NFAT-luciferase reporter. As shown in Fig. 3 A, we observed a striking inhibition in N F A T activation in T cells expressing the chimera containing NKB1 when compared to a truncated CD8 molecule (CD8/T). Thus, the cytoplasmic region o f NKB1 is sufficient to inhibit T C R -m e d i a t e d downstream gene activation in Jurkat T cells. NKB1 has also bee** implicated in the negative regulation o f I F N -~/ a n d T N F -a product/o** in NKB1 + T cell clones (25) . Therefore, NKB1 appears to regulate both cytolytic and nonqm~ytic effector functions in T ceils.
Inhibition by N t~t Is Me~'ated by the Tyrosines in the KIR
Consensus Motif. To further study the structural importance o f phosphotyrosines in the inhibitory signal of NKB1, we transiendy expressed the tyrosine mutant constructs (Fig. 2 A) and assessed their ability to inhibit T C gmediated N F A T activat~or,. The mutation o f both tyrosmes (F1F2) completely abolished the mhl~dtory effect of NKB1 (Fig. 3 B) . This effect was not ca~tsed by expression levels because the F1F2 mutant was present at much higher levels than the C D 8 / N K B i chimera, based on flow cytometry atmtysis. Therefore, loss ofiahibition must be a consequence o f the tyrosme matatioas OfPTP1 C,mzyme ac0vi~ with a phos--phorytated i~eptide containing the fiu, t qrrosine [pY1) from the K I R motif dam wirk a peptide contmmng the second tyrosine (pY2). The difference in inhibition between F1 and F2 detected in our in vivo assay may reflect either differential binding to PTP1 C or differences in phosphatase activation.
The K I R consensus m o t i f is very similar to the I T A M motif present in T C R and B C R subunits. The two tyrosines in the I T A M motif are important for Z A P -7 0 / S y k binding (8) . In the crystal structure o f ZAP-70 bound to a phosphorytatext peptide, the SH2 domains are in a fixed position and oriented in such a way as to place strict spatial constraints on the spacing between tyrosines in the I T A M (26) . W e tested whether the tyrosines in the K I R motif were also spaced at a stericaUy important distance, We deleted 18 amino acids between the two tyrosines in the NKB1 KIR motif (Fig. 2 A) and tested the mutant for its abihty to inhibit TCR-mediated NFAT activation. As Fig.  3 B demonstrates, the expression of this mutant (18-aa del) inhibited NFAT activation to the same degree as the wildtype CD8/NKB1 chimera. Thus, altering the spacing between tyrosines did not affect the inhibitory effect ofNKB1, suggesting that the spacing is not essential in the protein interactions that mediate inhibition. The crystal structure of the SH2 domains of the related PTP PTP1D bound to phosphotyrosine peptides may offer an explanation for these findings. The SH2 domains of PTPID are fixed in orientation, like the ZAP-70 SH2 domains, but in contrast to ZAP-70, they are oriented such that the phosphotyrosine peptides are roughly antiparalleI relative to each other (27) . This suggests that the binding of the SH2 domains of PTPID and related phosphatases like PTPIC to phosphotyrosines may not occur in tandem, like ZAP-70, but on two separate proteins in trans. Thus, alteration of the spacing between the two tyrosines in the KIR motif might not affect PTPIC binding.
In summary, we demonstrate that expression of the cytoplasmic domain of the KIR NKB1 in a chimeric receptor inhibits TCK-mediated downstream gene activation in Jurkat T cells. Tyrosine phosphorylation of the NKB1 chimera in Jurkat cells induced association between PTP1C and the chimeric receptor. Mutations of both tyrosines abolished the ability of NKB1 to both inhibit TCR activation and to bind PTP1C. The in vitro peptide-binding studies suggest that optimal binding of PTP1C to the KItK motif occurs when both tyrosines are phosphorylated. However, the single tyrosine mutants (F1 or F2) retained their ability to inhibit TCK activation, suggesting that PTP1C association with KI1K proteins may occur in cis or trans.
The membrane-proximal tyrosine plays a crucial role in mediating the inhibitory signal. In contrast to the tyrosine mutations, alteration of the spacing between tyrosines in the KIP, consensus motif did not affect the inhibitory signal. These results support a model in which PTP1C plays a role in mediating the negative signal transmitted by NKB1 and are consistent with studies by Burshtyn et al. (9) . Future studies on the targets of NKB1 will further clarify its role in modulating TCR-mediated signals.
